Publicaciones en las que colabora con ARANTXA ISLA RUIZ (9)

2022

  1. Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study

    Journal of Intensive Care, Vol. 10, Núm. 1

2021

  1. Pharmacotherapeutic management of Parkinson's disease inpatients: How about asking hospital pharmacists?

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E140-E145

  2. Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function

    Pharmaceutics, Vol. 13, Núm. 10

2018

  1. Augmented Renal Clearance in Critically Ill Patients: A Systematic Review

    Clinical Pharmacokinetics, Vol. 57, Núm. 9, pp. 1107-1121

2017

  1. El hipo en la Enfermedad de Parkinson

    Congreso SEFIG (13º. Alcalá de Henares. 2017)

  2. Hiccups in Parkinson’s disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature

    European Journal of Clinical Pharmacology, Vol. 73, Núm. 9, pp. 1159-1164

  3. Medication errors in Parkinson's disease inpatients in the Basque Country

    Parkinsonism and Related Disorders, Vol. 36, pp. 57-62

2015

  1. Anticholinergic burden in Parkinson's disease inpatients

    European Journal of Clinical Pharmacology, Vol. 71, Núm. 10, pp. 1271-1277

  2. Impacto de las acciones de mejora para el control farmacoterapéutico de la insuficiencia cardíaca en atención primaria

    Congreso Nacional de Atención Farmacéutica (9º. Toledo. 2015)